Devenyi R, Hamedani A
Curr Neurol Neurosci Rep. 2024; 24(8):273-284.
PMID: 38907811
PMC: 11258179.
DOI: 10.1007/s11910-024-01349-8.
Phan T, Baratono S, Drew W, Tetreault A, Fox M, Darby R
Ann Neurol. 2024; 95(5):929-940.
PMID: 38400760
PMC: 11060923.
DOI: 10.1002/ana.26894.
Nakata T, Shimada K, Iba A, Oda H, Terashima A, Koide Y
Jpn J Radiol. 2023; 42(3):308-318.
PMID: 37861956
DOI: 10.1007/s11604-023-01501-3.
Nosaka H, Onoguchi M, Tsushima H, Suda M, Kurata S, Onoma A
Sci Rep. 2022; 12(1):168.
PMID: 34997080
PMC: 8742003.
DOI: 10.1038/s41598-021-04078-x.
Morris E, Zaheed A, Sharifian N, Sol K, Kraal A, Zahodne L
J Clin Exp Neuropsychol. 2021; 43(3):310-323.
PMID: 34018454
PMC: 9590635.
DOI: 10.1080/13803395.2021.1926436.
Causal structural covariance network revealing atrophy progression in Alzheimer's disease continuum.
Qing Z, Chen F, Lu J, Lv P, Li W, Liang X
Hum Brain Mapp. 2021; 42(12):3950-3962.
PMID: 33978292
PMC: 8288084.
DOI: 10.1002/hbm.25531.
Brain metabolic signatures across the Alzheimer's disease spectrum.
Sala A, Caprioglio C, Santangelo R, Vanoli E, Iannaccone S, Magnani G
Eur J Nucl Med Mol Imaging. 2019; 47(2):256-269.
PMID: 31811345
DOI: 10.1007/s00259-019-04559-2.
Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies.
Sala A, Caminiti S, Iaccarino L, Beretta L, Iannaccone S, Magnani G
Hum Brain Mapp. 2019; 40(15):4537-4550.
PMID: 31322307
PMC: 6917031.
DOI: 10.1002/hbm.24719.
Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
Caminiti S, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L
Alzheimers Res Ther. 2019; 11(1):20.
PMID: 30797240
PMC: 6387558.
DOI: 10.1186/s13195-019-0473-4.
White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging.
Nedelska Z, Schwarz C, Boeve B, Lowe V, Reid R, Przybelski S
Neurobiol Aging. 2015; 36(6):2010-7.
PMID: 25863527
PMC: 4433563.
DOI: 10.1016/j.neurobiolaging.2015.03.007.
On visual hallucinations and cortical networks: a trans-diagnostic review.
Carter R, Ffytche D
J Neurol. 2015; 262(7):1780-90.
PMID: 25761375
PMC: 4503861.
DOI: 10.1007/s00415-015-7687-6.
Clinical Reasoning: a 75-year-old man with 3 years of visual difficulties.
Berkowitz A, Rose M, Daffner K, Prasad S
Neurology. 2014; 83(17):e160-5.
PMID: 25332451
PMC: 4222854.
DOI: 10.1212/WNL.0000000000000904.
Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.
Nedelska Z, Ferman T, Boeve B, Przybelski S, Lesnick T, Murray M
Neurobiol Aging. 2014; 36(1):452-61.
PMID: 25128280
PMC: 4268128.
DOI: 10.1016/j.neurobiolaging.2014.07.005.
Using structural and diffusion magnetic resonance imaging to differentiate the dementias.
Suri S, Topiwala A, Mackay C, Ebmeier K, Filippini N
Curr Neurol Neurosci Rep. 2014; 14(9):475.
PMID: 25030502
DOI: 10.1007/s11910-014-0475-3.
Multivariate classification of patients with Alzheimer's and dementia with Lewy bodies using high-dimensional cortical thickness measurements: an MRI surface-based morphometric study.
Lebedev A, Westman E, Beyer M, Kramberger M, Aguilar C, Pirtosek Z
J Neurol. 2012; 260(4):1104-15.
PMID: 23224109
DOI: 10.1007/s00415-012-6768-z.
Characterizing dementia with Lewy bodies by means of diffusion tensor imaging.
Watson R, Blamire A, Colloby S, Wood J, Barber R, He J
Neurology. 2012; 79(9):906-14.
PMID: 22895591
PMC: 3425843.
DOI: 10.1212/WNL.0b013e318266fc51.
Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study.
Taylor J, Firbank M, He J, Barnett N, Pearce S, Livingstone A
Br J Psychiatry. 2012; 200(6):491-8.
PMID: 22500014
PMC: 3365275.
DOI: 10.1192/bjp.bp.111.099432.
Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study.
Taylor J, Firbank M, Barnett N, Pearce S, Livingstone A, Mosimann U
Br J Psychiatry. 2011; 199(6):492-500.
PMID: 22016436
PMC: 3227808.
DOI: 10.1192/bjp.bp.110.090373.
Cerebral correlates of psychotic syndromes in neurodegenerative diseases.
Jellinger K
J Cell Mol Med. 2011; 16(5):995-1012.
PMID: 21418522
PMC: 4365880.
DOI: 10.1111/j.1582-4934.2011.01311.x.
Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.
Kono A, Ishii K, Sofue K, Miyamoto N, Sakamoto S, Mori E
Eur J Nucl Med Mol Imaging. 2007; 34(9):1490-7.
PMID: 17318545
DOI: 10.1007/s00259-007-0380-y.